Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Ildong Pharmaceutical Co., Ltd. (249420) Stock Price & Analysis

249420 Stock Chart & Stats

₩12,710.00₩360.00(2.91%)
At close: 3:30 PM GMT+9
₩12K₩14K₩16KAug 10Aug 24Sep 7Sep 21Oct 6Oct 19Nov 2
Day’s Range
KRW 12,500.00 - KRW 13,060.00
52-Week Range
KRW 11,250.00 - KRW 45,050.00
Previous Close
KRW 12,350.00
Volume
N/A
Average Volume (3M)
146.63K
Market Cap
KRW 390.51B
Enterprise Value
KRW 605.83B
Total Cash (Recent Filing)
KRW 60.37B
Total Debt (Recent Filing)
KRW 142.05B
Price to Earnings (P/E)
22.0
Beta
0.28
Next Earnings
Mar 18, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Mar 30, 2026
Dividend Yield
1.57%

Bulls Say, Bears Say

Bulls Say

Profitability Turnaround

The shift from substantial losses to positive and improving net income indicates a meaningful turnaround in the earnings cycle. If maintained, stronger profitability can support reinvestment, improve financial resilience, and provide a more durable base for future pharmaceutical growth.

Lower Leverage

Material deleveraging has strengthened the balance sheet and reduced dependence on borrowed capital. A lower debt-to-equity ratio should improve financial flexibility, lessen pressure from interest obligations, and give management more capacity to fund operations through a softer earnings period.

Improved Cash Generation

The move to positive operating and free cash flow provides important support for the turnaround because earnings are increasingly accompanied by internal cash generation. This can help fund working capital, debt service, and investment without relying as heavily on external financing.

Bears Say

Weak Operating Profitability

Negative operating and EBITDA margins show that the reported net profit is not currently matched by healthy profitability from core operations. This raises concerns about earnings quality and suggests that elevated operating costs or below-operating items could limit the durability of the recovery.

Revenue Volatility

Large swings in revenue growth make it harder to assess the company’s underlying demand trajectory and plan capacity or investment confidently. Continued volatility could weaken operating leverage, complicate forecasting, and make recent earnings improvement less dependable over the next several quarters.

Inconsistent Cash Conversion

Low operating cash flow relative to revenue and sharp year-to-year free-cash-flow swings indicate that accounting earnings are not yet converting consistently into cash. This may constrain self-funded growth and leave liquidity more exposed if working-capital or timing effects reverse.

249420 FAQ

What was Ildong Pharmaceutical Co., Ltd.’s price range in the past 12 months?
Ildong Pharmaceutical Co., Ltd. lowest stock price was ₩11250.00 and its highest was ₩45050.00 in the past 12 months.
What is Ildong Pharmaceutical Co., Ltd.’s market cap?
Ildong Pharmaceutical Co., Ltd.’s market cap is ₩390.51B.
When is Ildong Pharmaceutical Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Ildong Pharmaceutical Co., Ltd.’s earnings last quarter?
Ildong Pharmaceutical Co., Ltd. released its earnings results on Nov 02, 2026. The company reported -₩123.3 earnings per share for the quarter.
Is Ildong Pharmaceutical Co., Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Ildong Pharmaceutical Co., Ltd. pay dividends?
Ildong Pharmaceutical Co., Ltd. pays a ― dividend of ₩200 which represents an annual dividend yield of 1.57%. See more information on Ildong Pharmaceutical Co., Ltd. dividends here
What is Ildong Pharmaceutical Co., Ltd.’s EPS estimate?
Ildong Pharmaceutical Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ildong Pharmaceutical Co., Ltd. have?
Ildong Pharmaceutical Co., Ltd. has 31,638,252 shares outstanding.
What happened to Ildong Pharmaceutical Co., Ltd.’s price movement after its last earnings report?
Ildong Pharmaceutical Co., Ltd. reported an EPS of -₩123.3 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Ildong Pharmaceutical Co., Ltd.?
Currently, no hedge funds are holding shares in KR:249420
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology